•
Sep 30, 2021

Soleno Therapeutics Q3 2021 Earnings Report

EPS
-$1.5
Previous year: -$1.65
-9.1%
Cash and Equivalents
$28.2M
Previous year: $56.1M
-49.8%
Free Cash Flow
-$5.41M
Previous year: -$6.17M
-12.3%
Total Assets
$42.6M
Previous year: $71.8M
-40.7%

Soleno Therapeutics

Soleno Therapeutics